Altamira Receives Regulatory Approval from the Ministry of Health to Expand COVAMID Trial for Bentrio in Acute COVID-19 into North Macedonia
Published on: Thursday 05 May 2022
Extending clinical study will complement the ongoing trial in BulgariaReaffirms it expects to complete the study in 3Q-22 subject to sufficient COVID-19 incidenceHAMILTON, BERMUDA / ACCESSWIRE / May 5, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announced that it has received regulatory approval from the North Macedonia Ministry of Health to extend the COVAMID clinical investigation of its Bentr
News source: https://finance.yahoo.com/news/altamira-receives-regulatory-approval-ministry-124700553.html
